Enhanced antihypertensive responses to Omapatrilat (OMA) relative to Fosinopril (FOS) in stroke-prone spontaneously rats (SHRSP) are independent of effects on renal sodium excretion | Zendy

AI Assistant Blog Pricing

Enhanced antihypertensive responses to Omapatrilat (OMA) relative to Fosinopril (FOS) in stroke-prone spontaneously rats (SHRSP) are independent of effects on renal sodium excretion

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.